Previous studies have shown that IQGAP1 is associated with shorter overall survival in patients with BLCA [42], BRCA [27], CRC [34], UCEC [43], LUAD [44], GBMLGG [32], and HNSC [45]. Here, IQGAP1 is linked to bladder transitional cell carcinoma.